Daily News Podcast

Opioids don’t top NSAIDs for chronic pain

Publish date: December 20, 2018

 

Opioids’ pain relief and physical function benefits don’t top NSAIDs in chronic noncancer pain. A barbershop-based hypertension intervention is still going strong a year later. Canakinumab has a remarkable effect on knee and hip replacement risk. And low-tech BMI compares favorably with body scanning for cardiometabolic screening.

Amazon Alexa

Apple Podcasts

Google Podcasts

Spotify

Recommended Reading

Novel Nordic Study Reveals Diclofenac’s Cardiovascular Risks
MDedge Neurology
TENS cuts fibromyalgia pain in large RCT
MDedge Neurology
Palliative care update highlights role of nonspecialists
MDedge Neurology
FDA approves sufentanil for adults with acute pain
MDedge Neurology
Opioids negatively affect breathing during sleep
MDedge Neurology
High rates of prescription opioid, benzodiazepine use observed in chronic liver disease
MDedge Neurology
Children with headache disorders may benefit from anti-CGRP mAb treatment
MDedge Neurology
Comorbid TBI & PTSD raise the risk for sleep disturbances, pain
MDedge Neurology
Opioid benefit small in chronic noncancer pain
MDedge Neurology
Insulin loses its starting spot
MDedge Neurology